Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.114366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Ramya Kannan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Small Interfering, Endosomes, Polyamines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Mitacs Inc.
Abstract (Originalsprache)
Efficient cytosolic delivery of RNA therapeutics remains a major challenge. In this study, we developed a polymer-incorporated lipid nanoparticle (p-LNP) platform by integrating a low-molecular-weight polyamine (NS102) into standard LNP formulations. Systematic evaluation revealed that the molecular weight and amine composition of the polymer significantly influenced the delivery performance and biocompatibility, with NS102 (Mw ∼1000 Da, exclusively tertiary amines) emerging as the optimal candidate. Incorporating 4.5 mol% NS102 into LNPs enhanced their pH-buffering capacity, endosomal escape, and RNA stability without altering key physicochemical properties. These improvements resulted in superior RNA delivery, evidenced by increased mRNA transfection efficiency and siRNA activity in mice following both intravenous and intramuscular administration. Specifically, the p-LNPs achieved up to a 100-fold increase in luciferase bioluminescence expression in the liver and reduced the effective dose (ED50) of siRNA against factor VII produced by the liver by 50 %, compared to standard LNPs. Moreover, the p-LNP formulations exhibited excellent biocompatibility, with no significant cytotoxicity or liver toxicity in mice. These findings highlight the potential of the p-LNP platform for advancing RNA-based therapeutics, offering a promising strategy to overcome existing delivery barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
- GeneStar Bioscience and NanoStar Pharmaceuticals, Vancouver, British Columbia, Canada.
- School of Pharmacy, Taipei Medical University, Taipei, Taiwan.
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada. Electronic address: shyh-dar.li@ubc.ca.
Förderung
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Mitacs Inc
Zitieren
APA
Kannan, R., Tran, B., Le, Q., Hohenwarter, L., Chao, P. H., Brar, V., Roesger, S., Chen, S., Zhao, F., Wu, J., Lee, A., Liou, J. P., & Li, S. D. (2025). Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.114366
Vancouver
Kannan R, Tran B, Le Q, Hohenwarter L, Chao PH, Brar V, et al. Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.114366
BibTeX
@article{Kannan2025,
author = {Kannan, Ramya and Tran, Binh and Le, Quan and Hohenwarter, Lukas and Chao, Po-Han and Brar, Vivekjot and Roesger, Sophie and Chen, Steven and Zhao, Feng and Wu, Jiamin and Lee, Angel and Liou, Jing-Ping and Li, Shyh-Dar},
title = {Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.114366}
}
EUVIMED